Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASDAQ
NASDAQ
Does amount matter when it comes to a biotech IPO?
EP Vantage
Wed, 09/25/19 - 11:55 am
IPOs
biotech
NASDAQ
BioNTech
ADC Therapeutics
Genmab steps up for a $500M IPO haul, with its sights on a record-setting market cap
Endpoints
Wed, 07/10/19 - 10:49 am
Genmab
IPOs
NASDAQ
Puretech-backed Karuna makes Nasdaq debut with $89M IPO
Endpoints
Sat, 06/29/19 - 02:31 pm
Karuna
IPOs
NASDAQ
PureTech
Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch
Endpoints
Mon, 04/15/19 - 12:11 pm
biotech
IPOs
NASDAQ
NextCure
Applied Therapeutics
Cortexyme
Chi Med
Milestone Pharmaceuticals
Private oncology outfit Oncternal uses GTx as shell to make Nasdaq debut
Endpoints
Thu, 03/7/19 - 10:27 am
Oncternal
GTx
NASDAQ
oncology
Genfit files for NASDAQ listing
BioCentury
Thu, 02/28/19 - 09:58 am
Genfit
NASH
NASDAQ
As shutdown stalls IPOs, companies mull creative paths to market
Biopharma Dive
Fri, 01/18/19 - 09:13 pm
SEC
NASDAQ
IPOs
After JPM, biotechs still scrambling for IPOs as Kaleido, Cirius file amid government shutdown
Fierce Biotech
Mon, 01/14/19 - 11:35 am
IPOs
Kaleido Biosciences
Cirius Therapeutics
NASDAQ
JPMHC 2019
government shutdown
New exchange may give biotechs alternative to NASDAQ, NYSE
BioCentury
Tue, 01/8/19 - 12:39 am
biotech
MEMX
NASDAQ
NYSE
Biofrontera cleared of wrongdoing in Nasdaq IPO
Fierce Biotech
Thu, 12/13/18 - 10:10 pm
Biofrontera
IPOs
NASDAQ
Bovie to rebrand as Apyx Medical, move to NASDAQ
Mass Device
Thu, 12/13/18 - 09:14 pm
Bovie Medical
Apyx Medical
devices
NASDAQ
Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?
Endpoints
Mon, 12/10/18 - 09:58 am
IPOs
biotech
NASDAQ
Gamida Cell raises $50M in NASDAQ IPO
BioCentury
Sat, 10/27/18 - 11:57 am
Gamida Cell
IPOs
NASDAQ
cell therapy
Hoth Therapeutics seeks IPO cash to battle eczema
Fierce Biotech
Fri, 10/12/18 - 10:21 am
Hoth Therapeutics
IPOs
NASDAQ
eczema
Allogene raises $324M in year's largest biotech IPO on NASDAQ
BioCentury
Wed, 10/10/18 - 10:56 pm
Allogene
IPOs
cell therapy
NASDAQ
Allogene IPO could be year's largest biotech listing on NASDAQ
BioCentury
Tue, 10/2/18 - 07:45 pm
IPOs
NASDAQ
Allogene
CAR-T
Israel-Based Gamida Cell Files for $69 Million IPO
BioSpace
Mon, 10/1/18 - 07:21 pm
Gamida Cell
IPOs
Israel
NASDAQ
Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
Endpoints
Thu, 09/27/18 - 11:55 am
NASDAQ
IPOs
Entasis
Urovant Sciences
Arvinas
Sutro BioPharma
A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino
Endpoints
Mon, 07/16/18 - 09:11 am
biotech
IPOs
NASDAQ
Allakos
Constellation Pharma
Crinetics Pharmaceuticals
Replimune
Rubius Therapeutics
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
Endpoints
Fri, 04/20/18 - 09:46 am
IPOs
MorphoSys
Surface Oncology
NASDAQ
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »